Prelude Capital Management’s Genetic Technologies Ltd. GENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-5
Closed 1787
2016
Q4
$0 Sell
5
-10
-67% ﹤0.01% 1771
2016
Q3
$1K Buy
+15
New +$1K ﹤0.01% 1475